Scarica l'app Stockscreener
0.77
1.31%
-0.0102
Precedente Chiudi:
$0.7802
Aprire:
$0.77
Volume 24 ore:
2,052
Relative Volume:
0.00
Capitalizzazione di mercato:
$37.38M
Reddito:
$1.14M
Utile/perdita netta:
$-72.84M
Rapporto P/E:
-0.4755
EPS:
-1.6193
Flusso di cassa netto:
$-63.64M
1 W Prestazione:
-4.95%
1M Prestazione:
+21.85%
6M Prestazione:
-62.80%
1 anno Prestazione:
-25.24%
Intervallo 1D:
$0.77
$0.785
Intervallo di 1 settimana:
$0.7541
$0.859
Portata 52W:
$0.5301
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Nome
Werewolf Therapeutics Inc
Settore
Industria
Telefono
617-952-0555
Indirizzo
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.77 | 37.87M | 1.14M | -72.84M | -63.64M | -1.6193 |
VRTX
Vertex Pharmaceuticals Inc
|
451.39 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
754.55 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
329.82 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
687.64 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.26 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-19 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-04-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-08-24 | Iniziato | Wedbush | Outperform |
| 2023-06-06 | Ripresa | Jefferies | Buy |
| 2021-09-10 | Iniziato | BofA Securities | Buy |
| 2021-05-25 | Iniziato | Evercore ISI | Outperform |
| 2021-05-25 | Iniziato | H.C. Wainwright | Buy |
| 2021-05-25 | Iniziato | Jefferies | Buy |
| 2021-05-25 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Werewolf Therapeutics Inc Borsa (HOWL) Ultime notizie
Aug Drivers: Is Werewolf Therapeutics Inc a speculative investment2026 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn
Biotech 'Lowballed' Landlord On Lease Exit, Suit Says - Law360
Werewolf Therapeutics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
HOWL Stock Price, Quote & Chart | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - ChartMill
Aug Setups: Is Intelligent Bio Solutions Inc part of any major index2026 Trends & Weekly Breakout Watchlists - baoquankhu1.vn
Michael J. Urban Net Worth (2026) - GuruFocus
Werewolf Therapeutics (HOWL) eyes 2026 catalysts following FDA guidance and encouraging INDUKINE results - MSN
RSI Check: Is Werewolf Therapeutics Inc stock trending bullishTrade Exit Report & Growth Oriented Trading Recommendations - baoquankhu1.vn
Analyst Downgrade: Is now the right time to enter Werewolf Therapeutics IncLayoff News & Real-Time Volume Triggers - baoquankhu1.vn
Werewolf Therapeutics (HOWL) finance VP reports stock and option holdings on Form 3 - Stock Titan
Werewolf Therapeutics stock rises over 5% after hours on workforce reduction, including executives - MSN
Werewolf Therapeutics (HOWL) Stock Analysis Report | Financials & Insights - Benzinga Japan
Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30 - MSN
Published on: 2026-03-05 15:55:35 - baoquankhu1.vn
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives - Stocktwits
HOWL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Tuesday - Defense World
HOWL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is now the right time to enter Werewolf Therapeutics IncTrade Entry Report & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Werewolf Therapeutics Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Werewolf Therapeutics announces plan to explore strategic alternatives - MSN
Werewolf Therapeutics explores sale and strategic alternatives - Investing.com India
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives - Investing News Network
Werewolf Therapeutics Begins Strategic Alternatives Review Process - TipRanks
Werewolf Therapeutics (HOWL) starts review of strategic options with Piper Sandler - Stock Titan
Werewolf Therapeutics explores sale and strategic alternatives By Investing.com - Investing.com South Africa
Werewolf to Explore Strategic Alternatives, Engages Piper Sandler as Exclusive Advisor - TradingView
Levels Update: Does Werewolf Therapeutics Inc have strong EBITDA marginsJuly 2025 Spike Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
HOWL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Why Werewolf Therapeutics Inc. stock could rally in 2025Portfolio Gains Summary & Smart Swing Trading Techniques - mfd.ru
IPO Launch: Does Werewolf Therapeutics Inc have strong EBITDA margins2025 Analyst Calls & Risk Controlled Daily Plans - baoquankhu1.vn
Werewolf Therapeutics stock falls after announcing 64% workforce reduction By Investing.com - Investing.com Canada
Werewolf Therapeutics stock falls after announcing 64% workforce reduction - Investing.com
Werewolf Therapeutics Cuts 64% of Workforce - marketscreener.com
Werewolf Therapeutics Announces Major Workforce and Leadership Restructuring - TipRanks
Werewolf Therapeutics, Inc. Announces Executive Changes, Effective February 13, 2026 - marketscreener.com
What insider trading reveals about Werewolf Therapeutics Inc. stockMarket Movers & Verified Momentum Stock Ideas - mfd.ru
What is the target price for Werewolf Therapeutics Inc. stock2025 AllTime Highs & Risk Controlled Stock Pick Alerts - mfd.ru
Is Werewolf Therapeutics Inc. impacted by rising ratesWeekly Investment Report & Safe Capital Investment Plans - mfd.ru
Aug Opening: Should I invest in Standard BioTools Inc before earningsWall Street Watch & AI Powered Market Trend Analysis - baoquankhu1.vn
Does Werewolf Therapeutics Inc. have strong EBITDA marginsJuly 2025 Final Week & Daily Stock Trend Watchlist - mfd.ru
Death Cross: Is now the right time to enter Werewolf Therapeutics Inc2025 Geopolitical Influence & Consistent Income Trade Ideas - baoquankhu1.vn
Werewolf Therapeutics (HOWL) upgraded to buy: Here's what you should know - MSN
Trading Action: Does Werewolf Therapeutics Inc have strong EBITDA marginsJuly 2025 Momentum & AI Driven Stock Price Forecasts - baoquankhu1.vn
Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency - Investing.com Nigeria
Werewolf Therapeutics Receives Nasdaq Minimum Bid Price Notice - TipRanks
Werewolf Therapeutics Received Notice of Noncompliance - TradingView
Werewolf Therapeutics Inc Azioni (HOWL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Werewolf Therapeutics Inc Azioni (HOWL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| EVNIN LUKE | Director |
Jan 13 '26 |
Sale |
0.55 |
43,198 |
23,759 |
2,266,671 |
| EVNIN LUKE | Director |
Jan 15 '26 |
Sale |
0.55 |
37,413 |
20,577 |
2,198,642 |
| EVNIN LUKE | Director |
Jan 14 '26 |
Sale |
0.57 |
30,616 |
17,451 |
2,236,055 |
| EVNIN LUKE | Director |
Jan 12 '26 |
Sale |
0.57 |
58,980 |
33,619 |
2,309,869 |
| EVNIN LUKE | Director |
Jan 09 '26 |
Sale |
0.61 |
24,678 |
15,054 |
2,368,849 |
| EVNIN LUKE | Director |
Jan 08 '26 |
Sale |
0.63 |
7,716 |
4,861 |
2,393,527 |
| EVNIN LUKE | Director |
Jan 06 '26 |
Sale |
0.65 |
40,761 |
26,495 |
2,413,158 |
| EVNIN LUKE | Director |
Jan 05 '26 |
Sale |
0.64 |
18,378 |
11,762 |
2,453,919 |
| EVNIN LUKE | Director |
Jan 07 '26 |
Sale |
0.64 |
11,915 |
7,626 |
2,401,243 |
0.99%
3.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):